EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023

preview_player
Показать описание
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience and a presentation by a patient advocate, Ivy Elkins.

In this video, Dr. Isabel Preeshagul gives a brief overview of EGFR, and discusses the mutations in advanced NSCLC.

BenSound License #: DSSHUIYGV4VQCETM

Thank you to our sponsors: #Takeda #Janssen #Lilly #Genentech #Mirati #ExactSciences #BMS #GEHealthcare.
  1. GRACE - Global Resource for Advancing Cancer Education
  2. GRACE
  3. CancerGRACE
  4. oncology
  5. cancer
  6. education
Рекомендации по теме
EGFR Mutations in 0:04:10

EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023

Evaluating the Role 0:01:14

Evaluating the Role of EGFR Mutations in the Treatment of Advanced NSCLC

The challenge of 0:01:26

The challenge of treatment resistance in patients with advanced EGFR-mutated NSCLC

Amivantamab and lazertinib 0:02:03

Amivantamab and lazertinib in treatment-naïve EGFR-mutant NSCLC

Dr. Levine on 0:02:11

Dr. Levine on Simulation in the Management of EGFR-Mutated Advanced NSCLC

Advancing Care for 0:53:55

Advancing Care for Patients With EGFR Mutation–Positive NSCLC: Precision Medicine Strategies

How do doctors 0:03:41

How do doctors treat lung cancer with EGFR mutations?

GRACECast - LCVL 0:10:39

GRACECast - LCVL - Can patients with an EGFR mutation-positive advanced NSCLC benefit from immunothe

Detectability of uncommon 0:01:21

Detectability of uncommon EGFR mutations in NSCLC: NGS versus PCR

2023 Best of 0:30:32

2023 Best of Lung: Targeted Therapies in Lung Cancer

ASSESS trial: Blood 0:02:05

ASSESS trial: Blood test for EGFR mutation in advanced non-small cell lung cancer

Molecular Testing for 1:01:27

Molecular Testing for EGFR Mutations: What Pathologists Need to Know

Understanding NSCLC Treatment 0:05:03

Understanding NSCLC Treatment When You Have an EGFR Mutation

Osimertinib in Advanced 0:03:02

Osimertinib in Advanced EGFR T790M-Mutant NSCLC

Therapeutic strategies for 0:02:23

Therapeutic strategies for EGFR-mutated lung cancer

EGFR-Mutant Lung Cancer 0:14:24

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient F...

Time for Even 0:58:24

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC

EGFR Mutations in 0:01:41

EGFR Mutations in Patients With Lung Cancer

Repeat biopsy in 0:03:34

Repeat biopsy in lung cancer patients with EGFR mutation

Treatment of EGFR 0:04:02

Treatment of EGFR Mutated NSCLC - 2022 Program: Targeted Therapies Forum - English

First Line Treatment 0:01:26

First Line Treatment of EGFR Mutation-Positive NSCLC

Surgery Options for 0:05:55

Surgery Options for NSCLC & I-O Therapy in EGFR-Mutations

Osimertinib: A potential 0:06:50

Osimertinib: A potential new standard of care for advanced EGFR-mutated NSCLC | Suresh Ramalingam

ASCO 2023 Highlights 0:06:20

ASCO 2023 Highlights on adjuvant osimertinib in resected EGFR mutated NSCLC: The ADAURA trial